SNRPA
U1 small nuclear ribonucleoprotein A
Also known as: Mud1, SNRPA_HUMAN, U1-A, U1A
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P09012
- Gene
- SNRPA
- Ensembl
- ENSG00000077312
- Chromosome
- 19
- Canonical length
- 282 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The protein encoded by this gene associates with stem loop II of the U1 small nuclear ribonucleoprotein, which binds the 5' splice site of precursor mRNAs and is required for splicing. The encoded protein autoregulates itself by polyadenylation inhibition of its own pre-mRNA via dimerization and has been implicated in the coupling of splicing and polyadenylation. [provided by RefSeq, Oct 2010]
Canonical amino-acid sequenceUniProt
282 residues, UniProt reviewed canonical sequence.
>P09012|SNRPA
1 MAVPETRPNH TIYINNLNEK IKKDELKKSL YAIFSQFGQI LDILVSRSLK MRGQAFVIFK
61 EVSSATNALR SMQGFPFYDK PMRIQYAKTD SDIIAKMKGT FVERDRKREK RKPKSQETPA
121 TKKAVQGGGA TPVVGAVQGP VPGMPPMTQA PRIMHHMPGQ PPYMPPPGMI PPPGLAPGQI
181 PPGAMPPQQL MPGQMPPAQP LSENPPNHIL FLTNLPEETN ELMLSMLFNQ FPGFKEVRLV
241 PGRHDIAFVE FDNEVQAGAA RDALQGFKIT QNNAMKISFA KKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SNRPA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 83 nTPM
Expression across tissuesHPA
Tissue
- ovary: 83 nTPM
- spleen: 77 nTPM
- blood vessel: 77 nTPM
- cervix: 71 nTPM
- endometrium: 66 nTPM
- thyroid gland: 66 nTPM
Single-cell type
- extravillous trophoblasts: 151 nCPM
- migrating cytotrophoblasts: 144 nCPM
- esophageal basal cells: 141 nCPM
- cytotrophoblasts: 111 nCPM
- alveolar cells type 2: 102 nCPM
- epididymal basal cells: 99 nCPM
Immune cell
- myeloid DC: 57 nTPM
- plasmacytoid DC: 35 nTPM
- memory CD8 T-cell: 32 nTPM
- intermediate monocyte: 32 nTPM
- T-reg: 32 nTPM
- naive CD4 T-cell: 30 nTPM
Brain region
- basal ganglia: 37 nTPM
- choroid plexus: 36 nTPM
- hypothalamus: 36 nTPM
- midbrain: 33 nTPM
- pons: 33 nTPM
- medulla oblongata: 33 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SNRPA.
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 47 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Spliceosomepathy
Disease | ImmuneIEDB
Conditions an epitope on SNRPA was assayed in.
- systemic lupus erythematosus B cell
- mixed connective tissue disease B cell
- rheumatoid arthritis B cell
- Sjogren's syndrome B cell
- systemic scleroderma B cell
- autoimmune disease of skin and connective tissue B cell
- systemic juvenile rheumatoid arthritis B cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against SNRPA are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for SNRPA from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
11 publications
- Mechanisms of autoantibody production in systemic lupus erythematosus.
2015 · Front Immunol · RCR 2.1 · 64 citations - Characterization of human variable domain antibody fragments against the U1 RNA-associated A protein, selected from a synthetic and patient-derived combinatorial V gene library.
1996 · Eur J Immunol · RCR 1 · 43 citations - Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
2000 · Arthritis Rheum · RCR 0.9 · 37 citations - Maintenance of autoantibody production in pristane-induced murine lupus.
2015 · Arthritis Res Ther · RCR 0.7 · 20 citations - Identification of Anti-SNRPA as a Novel Serological Biomarker for Systemic Sclerosis Diagnosis.
2023 · J Proteome Res · RCR 0.6 · 5 citations
Show 6 more
- Maintenance of anti-Sm/RNP autoantibody production by plasma cells residing in ectopic lymphoid tissue and bone marrow memory B cells.
2013 · J Immunol · RCR 0.4 · 19 citations - In vivo tolerance breakdown with dendritic cells pulsed with U1A protein in non-autoimmune mice: the induction of a high level of autoantibodies but not renal pathological changes.
2002 · Immunology · RCR 0.3 · 15 citations - Interferons (IFN-A/-B/-G) Genetic Variants in Patients with Mixed Connective Tissue Disease (MCTD).
2019 · J Clin Med · RCR 0.2 · 4 citations - MHC class II gene associations with autoantibodies to U1A and SmD1 proteins.
1999 · Int Immunol · RCR 0.2 · 8 citations - Heavy chain CDR3 optimization of a germline encoded recombinant antibody fragment predisposed to bind the U1A protein.
1997 · Protein Eng · RCR 0.1 · 5 citations - Autoantibodies that stabilize U1snRNP are a significant component of human autoantibodies to snRNP and delay proteolysis of sm antigens in vitro.
2004 · J Rheumatol · RCR 0.1 · 3 citations
Reference: B cellIEDB
10 publications
- Linear epitope mapping of an Sm B/B' polypeptide.
1992 · J Immunol · RCR 2.3 · 92 citations - Mapping of epitopes on U1 snRNP polypeptide A with synthetic peptides and autoimmune sera.
1991 · Clin Exp Immunol · RCR 1.5 · 51 citations - A repeated proline-rich sequence in Sm B/B' and N is a dominant epitope recognized by human and murine autoantibodies.
1990 · J Autoimmun · RCR 0.8 · 30 citations - Human lupus anti-spliceosome A protein autoantibodies bind contiguous surface structures and segregate into two sequential epitope binding patterns.
1996 · J Immunol · RCR 0.8 · 33 citations - Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosus.
2009 · Arthritis Rheum · RCR 0.7 · 30 citations
Show 5 more
- Peptide autoantigenicity of the small nuclear ribonucleoprotein C.
1995 · Clin Exp Rheumatol · RCR 0.7 · 27 citations - A population of autoantibodies against a centromere-associated protein A major epitope motif cross-reacts with related cryptic epitopes on other nuclear autoantigens and on the Epstein-Barr nuclear antigen 1.
2001 · J Mol Med (Berl) · RCR 0.6 · 28 citations - A limited lupus anti-spliceosomal response targets a cross-reactive, proline-rich motif.
1998 · J Autoimmun · RCR 0.3 · 12 citations - Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease.
2011 · Lupus · RCR 0.2 · 9 citations - MHC class II gene associations with autoantibodies to U1A and SmD1 proteins.
1999 · Int Immunol · RCR 0.2 · 8 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.39
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.75
- DepMap mean gene effect
- -0.37
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- via spliceosome
- mRNA splicing
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA recognition motif domain
- Nucleotide-binding alpha-beta plait domain superfamily
- RNA-binding domain superfamily
- RNA recognition motif
- U1 small nuclear ribonucleoprotein A, RNA recognition motif 1
- U1 small nuclear ribonucleoprotein A, RNA recognition motif 2
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SNRPA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SNRPA as an antibody target. Whether an autoantibody or antibody against SNRPA could matter depends on whether native SNRPA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SNRPA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SNRPA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...